Literature DB >> 36074321

Eye Involvement and Management in Inherited Epidermolysis Bullosa.

Yasmine Bachir1, Alejandra Daruich1,2, Couanon Marie1, Matthieu P Robert1, Dominique Bremond-Gignac3,4.   

Abstract

Inherited epidermolysis bullosa (EB) is a group of genetic rare diseases associated with skin fragility, which leads to the formation of blisters, erosions, and scars on the skin and mucous membranes. Epidermolysis bullosa includes four main types and some several clinical subtypes including EB simplex, junctional EB, dystrophic EB, and Kindler's EB. Ocular involvement ranged from 51 to 68% in EB and can cause irreversible damages if not properly managed. Corneal erosions are the most common finding among series, including our cohort. We review here clinical and pathological features of ocular involvement in EB and the main keys for management, with a focus on recent innovative therapies.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Year:  2022        PMID: 36074321     DOI: 10.1007/s40265-022-01770-8

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   11.431


  59 in total

Review 1.  Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part II. Other organs.

Authors:  Jo-David Fine; Jemima E Mellerio
Journal:  J Am Acad Dermatol       Date:  2009-09       Impact factor: 11.527

Review 2.  Diagnosis and classification of autoimmune blistering diseases.

Authors:  Sharon Baum; Nicole Sakka; Ofir Artsi; Henri Trau; Aviv Barzilai
Journal:  Autoimmun Rev       Date:  2014-01-13       Impact factor: 9.754

Review 3.  Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification.

Authors:  Jo-David Fine; Leena Bruckner-Tuderman; Robin A J Eady; Eugene A Bauer; Johann W Bauer; Cristina Has; Adrian Heagerty; Helmut Hintner; Alain Hovnanian; Marcel F Jonkman; Irene Leigh; M Peter Marinkovich; Anna E Martinez; John A McGrath; Jemima E Mellerio; Celia Moss; Dedee F Murrell; Hiroshi Shimizu; Jouni Uitto; David Woodley; Giovanna Zambruno
Journal:  J Am Acad Dermatol       Date:  2014-03-29       Impact factor: 11.527

Review 4.  Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility.

Authors:  C Has; J W Bauer; C Bodemer; M C Bolling; L Bruckner-Tuderman; A Diem; J-D Fine; A Heagerty; A Hovnanian; M P Marinkovich; A E Martinez; J A McGrath; C Moss; D F Murrell; F Palisson; A Schwieger-Briel; E Sprecher; K Tamai; J Uitto; D T Woodley; G Zambruno; J E Mellerio
Journal:  Br J Dermatol       Date:  2020-03-11       Impact factor: 9.302

Review 5.  Epidermolysis bullosa acquisita: A comprehensive review.

Authors:  Khalaf Kridin; Diana Kneiber; Eric H Kowalski; Manuel Valdebran; Kyle T Amber
Journal:  Autoimmun Rev       Date:  2019-06-07       Impact factor: 9.754

Review 6.  Inherited epidermolysis bullosa: New diagnostics and new clinical phenotypes.

Authors:  Cristina Has; Judith Fischer
Journal:  Exp Dermatol       Date:  2018-06-28       Impact factor: 3.960

7.  The eye in epidermolysis bullosa.

Authors:  L Tong; P R Hodgkins; J Denyer; D Brosnahan; J Harper; I Russell-Eggitt; D S Taylor; D Atherton
Journal:  Br J Ophthalmol       Date:  1999-03       Impact factor: 4.638

Review 8.  Extended Wear Bandage Contact Lenses Decrease Pain and Preserve Vision in Patients with Epidermolysis Bullosa: Case Series and Review of Literature.

Authors:  Ramy Rashad; Matthew C Weed; Nicole Quinn; Vicki M Chen
Journal:  Ocul Immunol Inflamm       Date:  2019-04-15       Impact factor: 3.070

9.  Epidemiology of Inherited Epidermolysis Bullosa Based on Incidence and Prevalence Estimates From the National Epidermolysis Bullosa Registry.

Authors:  Jo-David Fine
Journal:  JAMA Dermatol       Date:  2016-11-01       Impact factor: 10.282

Review 10.  Inherited epidermolysis bullosa: update on the clinical and genetic aspects.

Authors:  Luiza Monteavaro Mariath; Juliana Tosetto Santin; Lavínia Schuler-Faccini; Ana Elisa Kiszewski
Journal:  An Bras Dermatol       Date:  2020-07-08       Impact factor: 1.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.